Home › Plexiform Neurofibroma › Pennsylvania › Philadelphia
Plexiform Neurofibroma clinical trials in Philadelphia, PA
4 studies for Plexiform Neurofibroma are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)
RecruitingObservational studyHealthy volunteers welcome
- Children's Hospital of Philadelphia, Philadelphia
Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas
RecruitingPhase 1
- Children's Hospital of Philadelphia, Philadelphia
A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
RecruitingPhase 2
- Children's Hospital of Philadelphia, Philadelphia
Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
RecruitingPhase 2
- Children's Hospital of Philadelphia, Philadelphia
Plexiform Neurofibroma trials in other cities
Other studies in Philadelphia
- Cancer (all types)60 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Prostate Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer29 studies
- Head and Neck Squamous Cell Carcinoma26 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.